Bonumose says FDA Sides With High Fructose Corn Syrup Producers and Against Consumers, By Suppressing Truthful Information About Tagatose
Internal FDA documents discovered via the Freedom of Information Act indicate a potential FDA bias against health-focused innovation and in favor of industrial corn sweetener producers.
Bonumose's Low-Cost Tagatose Process Receives Key Health Agency Approvals, Construction of First Production Facility on Schedule for Spring 2022 Opening
ASR Group – exclusive sales and distribution partner – reports strong customer demand for the unique, rare sugar, accelerating the timeline for a second production plant.
Bonumose is pleased to announce the issuance of U.S. Patent No. 11,078,506 for “Enzymatic Production of D-Allulose”.
Bonumose Biochem was selected as one of 24 early-stage companies to present at the Council for Entrepreneurial Development’s Life Science Conference 2017, to be held February 28-March 1 in Raleigh,...